Javed Butler相关文献与解析，生知库 | 链接生命科学的每一步

Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

恩格列净对射血分数保留型和中等射血分数型心力衰竭的疗效：EMPEROR-Preserved 的预先指定分析

doi:10.1038/s41591-022-02041-5

Stefan D Anker, Javed Butler, Muhammad Shariq Usman, Gerasimos Filippatos, João Pedro Ferreira, Edimar Bocchi, Michael Böhm, Hans Pieter Brunner-La Rocca, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure, Nadia Giannetti, Juan Esteban Gomez-Mesa, Stefan Janssens, James L Januzzi, José R González-Juanat

Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced

贫血的影响以及恩格列净对射血分数降低的心力衰竭的作用：EMPEROR-Reduced 的研究结果

期刊:European Journal of Heart Failure

影响因子:16.9

doi:10.1002/ejhf.2409

João Pedro Ferreira, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Tomoko Iwata, Afshin Salsali, Cordula Zeller, Stuart J Pocock, Faiez Zannad, Milton Packer0

Hypertensive Diseases in Pregnancy and Kidney Function Later in Life: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study

妊娠期高血压疾病与晚年肾功能：动脉病遗传流行病学网络（GENOA）研究

期刊:Mayo Clinic Proceedings

影响因子:6.7

doi:10.1016/j.mayocp.2021.07.018

Oshunbade, Adebamike A; Lirette, Seth T; Windham, B Gwen; Shafi, Tariq; Hamid, Arsalan; Gbadamosi, Semiu O; Tin, Adrienne; Yimer, Wondwosen K; Tibuakuu, Martin; Clark, Donald 3rd; Kamimura, Daisuke; Lutz, Elizabeth A; Mentz, Robert J; Fox, Ervin R; Butler, Javed; Butler, Kenneth R; Garovic, Vesna D; Turner, Stephen T; Mosley, Thomas H Jr; Hall, Michael E

Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

地区和种族对射血分数降低的心力衰竭患者对恩格列净反应的影响：EMPEROR-Reduced 试验

期刊:European Heart Journal

影响因子:37.6

doi:10.1093/eurheartj/ehab360

Carolyn S P Lam, João Pedro Ferreira, Egon Pfarr, David Sim, Hiroyuki Tsutsui, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Naveed Sattar, Subodh Verma, Martina Brueckmann, Janet Schnee, Daniel Cotton, Faiez Zannad, Milton Packer5

Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial

预测慢性心力衰竭发病率和死亡率的新型生物标志物驱动预后模型：EMPEROR-Reduced 试验

期刊:European Heart Journal

影响因子:37.6

doi:10.1093/eurheartj/ehab579

Stuart J Pocock, João Pedro Ferreira, John Gregson, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Nicholas D Gollop, Tomoko Iwata, Martina Brueckmann, James L Januzzi, Adriaan A Voors, Faiez Zannad, Milton Packer5

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced

恩格列净在治疗各种肾功能类型的心力衰竭时对心脏和肾脏的益处：EMPEROR-Reduced 的见解

期刊:Circulation

影响因子:35.5

doi:10.1161/CIRCULATIONAHA.120.051685

Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, Cordula Zeller, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Sibylle Jenny Hauske, Martina Brueckmann, Egon Pfarr, Janet Schnee, Christoph Wanner, Milton Packer4

Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN-HF Registry

心力衰竭患者的电解剖比率和死亡率：来自 ASIAN-HF 登记处的见解

期刊:Journal of the American Heart Association

影响因子:5

doi:10.1161/JAHA.120.017932

Janice Y Chyou, Wan Ting Tay, Inder S Anand, Tiew-Hwa Katherine Teng, Jonathan J L Yap, Michael R MacDonald, Vijay Chopra, Seet Yoong Loh, Wataru Shimizu, Imran Zainal Abidin; ASIAN‐HF Investigators; Arthur Mark Richards, Javed Butler, Carolyn S P Lam1

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes

揭示恩格列净在伴有或不伴有糖尿病的射血分数降低的心力衰竭中的作用分子机制

期刊:Jacc-Basic To Translational Science

影响因子:8.4

doi:10.1016/j.jacbts.2019.07.010

Oriol Iborra-Egea, Evelyn Santiago-Vacas, Salva R Yurista, Josep Lupón, Milton Packer, Stephane Heymans, Faiez Zannad, Javed Butler, Domingo Pascual-Figal, Antonio Lax, Julio Núñez, Rudolf A de Boer, Antoni Bayés-Genís

Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection

HIV 感染患者的生物标志物簇与心脏表型和死亡率的关联

期刊:Circulation-Heart Failure

影响因子:7.8

doi:10.1161/CIRCHEARTFAILURE.117.004312

Rebecca Scherzer, Sanjiv J Shah, Eric Secemsky, Javed Butler, Carl Grunfeld, Michael G Shlipak, Priscilla Y Hsue

SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence

SGLT-2 抑制剂在心力衰竭中的作用：当前证据的回顾

Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

恩格列净对射血分数保留型和中等射血分数型心力衰竭的疗效：EMPEROR-Preserved 的预先指定分析

Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced

贫血的影响以及恩格列净对射血分数降低的心力衰竭的作用：EMPEROR-Reduced 的研究结果

Hypertensive Diseases in Pregnancy and Kidney Function Later in Life: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study

妊娠期高血压疾病与晚年肾功能：动脉病遗传流行病学网络（GENOA）研究

Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

地区和种族对射血分数降低的心力衰竭患者对恩格列净反应的影响：EMPEROR-Reduced 试验

Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial

预测慢性心力衰竭发病率和死亡率的新型生物标志物驱动预后模型：EMPEROR-Reduced 试验

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced

恩格列净在治疗各种肾功能类型的心力衰竭时对心脏和肾脏的益处：EMPEROR-Reduced 的见解

Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN-HF Registry

心力衰竭患者的电解剖比率和死亡率：来自 ASIAN-HF 登记处的见解

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes

揭示恩格列净在伴有或不伴有糖尿病的射血分数降低的心力衰竭中的作用分子机制

Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection

HIV 感染患者的生物标志物簇与心脏表型和死亡率的关联